New drug aims to cool hidden heart inflammation after attack
Disease control
Recruiting now
This study tests a drug called orticumab in 240 people who had a heart attack and still have high inflammation in their heart arteries. The goal is to see if orticumab can lower that inflammation better than a placebo over 6 months, using special CT scans to measure changes. Part…
Phase: PHASE2 • Sponsor: Abcentra • Aim: Disease control
Last updated May 15, 2026 11:57 UTC